169 related articles for article (PubMed ID: 22957306)
1. BRCA1 proteins regulate growth of ovarian cancer cells by tethering Ubc9.
Qin Y; Xu J; Aysola K; Oprea G; Reddy A; Matthews R; Okoli J; Cantor A; Grizzle WE; Partridge EE; Reddy ES; Landen C; Rao VN
Am J Cancer Res; 2012; 2(5):540-8. PubMed ID: 22957306
[TBL] [Abstract][Full Text] [Related]
2. Ubc9 mediates nuclear localization and growth suppression of BRCA1 and BRCA1a proteins.
Qin Y; Xu J; Aysola K; Begum N; Reddy V; Chai Y; Grizzle WE; Partridge EE; Reddy ES; Rao VN
J Cell Physiol; 2011 Dec; 226(12):3355-67. PubMed ID: 21344391
[TBL] [Abstract][Full Text] [Related]
3. A Novel Pathway that Links Caveolin-1 Down-Regulation to BRCA1 Dysfunction in Serous Epithelial Ovarian Cancer Cells.
Xu J; Agyemang S; Qin Y; Aysola K; Giles M; Oprea G; O'Regan RM; Partridge EE; Harris-Hooker S; Rice VM; Reddy ES; Rao VN
Enliven Chall Cancer Detect Ther; 2014; 1(1):. PubMed ID: 25594072
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 Mutation Leads to Deregulated Ubc9 Levels which Triggers Proliferation and Migration of Patient-Derived High Grade Serous Ovarian Cancer and Triple Negative Breast Cancer Cells.
Xu J; Footman A; Qin Y; Aysola K; Black S; Reddy V; Singh K; Grizzle W; You S; Moellering D; Reddy ES; Fu Y; Rao VN
Int J Chronic Dis Ther; 2016; 2(3):31-38. PubMed ID: 28164176
[TBL] [Abstract][Full Text] [Related]
5. A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells.
Xu J; Watkins T; Reddy A; Reddy ES; Rao VN
Int J Oncol; 2009 Apr; 34(4):939-49. PubMed ID: 19287951
[TBL] [Abstract][Full Text] [Related]
6. A novel Ubc9 -dependent pathway regulates SIRT1- ER-α Axis and BRCA1-associated TNBC lung metastasis.
Xu J; Shumate C; Qin Y; Reddy V; Burnam Y; Lopez V; Okoli J; P Reddy ES; Rao VN
Integr Mol Med; 2017 Aug; 4(4):. PubMed ID: 31341634
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins.
Maniccia AW; Lewis C; Begum N; Xu J; Cui J; Chipitsyna G; Aysola K; Reddy V; Bhat G; Fujimura Y; Henderson B; Reddy ES; Rao VN
J Cell Physiol; 2009 Jun; 219(3):634-41. PubMed ID: 19170108
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanism Linking BRCA1 Dysfunction to High Grade Serous Epithelial Ovarian Cancers with Peritoneal Permeability and Ascites.
Desai A; Xu J; Aysola K; Akinbobuyi O; White M; Reddy VE; Okoli J; Clark C; Partridge EE; Childs E; Beech DJ; Rice MV; Reddy E; Rao VN
J Gynecol Res; 2015; 1(1):. PubMed ID: 26665166
[TBL] [Abstract][Full Text] [Related]
10. BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers.
Yuli C; Shao N; Rao R; Aysola P; Reddy V; Oprea-llies G; Lee L; Okoli J; Partridge E; Reddy ES; Rao VN
Oncogene; 2007 Sep; 26(41):6031-7. PubMed ID: 17384678
[TBL] [Abstract][Full Text] [Related]
11. c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells.
Chai Y; Chipitsyna G; Cui J; Liao B; Liu S; Aysola K; Yezdani M; Reddy ES; Rao VN
Oncogene; 2001 Mar; 20(11):1357-67. PubMed ID: 11313879
[TBL] [Abstract][Full Text] [Related]
12. Differential transcriptional activation by the N-terminal region of BRCA1 splice variants BRCA1a and BRCA1b.
Cui JQ; Wang H; Reddy ES; Rao VN
Oncol Rep; 1998; 5(3):585-9. PubMed ID: 9538156
[TBL] [Abstract][Full Text] [Related]
13. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter.
Chai YL; Cui J; Shao N; Shyam E; Reddy P; Rao VN
Oncogene; 1999 Jan; 18(1):263-8. PubMed ID: 9926942
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor alpha and nuclear factor Y coordinately regulate the transcription of the SUMO-conjugating UBC9 gene in MCF-7 breast cancer cells.
Ying S; Dünnebier T; Si J; Hamann U
PLoS One; 2013; 8(9):e75695. PubMed ID: 24086615
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and molecular significance of Sumolyation marker (ubiquitin conjugating enzyme 9 (UBC9)) expression in breast cancer of black women.
Agboola AO; Musa AA; Ayoade BA; Banjo AA; Anunobi CC; Deji-Agboola AM; Rakha EA; Nolan C; Ellis IO; Green AR
Pathol Res Pract; 2014 Jan; 210(1):10-7. PubMed ID: 24176171
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-conjugating enzyme 9 promotes epithelial ovarian cancer cell proliferation in vitro.
Dong M; Pang X; Xu Y; Wen F; Zhang Y
Int J Mol Sci; 2013 May; 14(6):11061-71. PubMed ID: 23708104
[TBL] [Abstract][Full Text] [Related]
17. Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.
Górski B
Hered Cancer Clin Pract; 2006 Aug; 4(3):142-52. PubMed ID: 20223018
[TBL] [Abstract][Full Text] [Related]
18. A Provocative Molecular Link between Mammographic Density and BRCA1-loss associated TNBC.
Xu J; Olusola G; Footman A; Hansen N; Cheriyan AM; Koganti K; Reddy V; Yezdani S; Eddy V; De'smond H; Bakinde N; Okoli J; Oprea G; Gundry K; Reddy ESP; Rao VN
Int J Hum Genet Genet Disord; 2019; 1(1):1-8. PubMed ID: 33860286
[TBL] [Abstract][Full Text] [Related]
19. A role for Ubc9 in tumorigenesis.
Mo YY; Yu Y; Theodosiou E; Ee PL; Beck WT
Oncogene; 2005 Apr; 24(16):2677-83. PubMed ID: 15735760
[TBL] [Abstract][Full Text] [Related]
20. Ovarian Cancer Gene Therapy with BRCA1-An Overview.
Obermiller PS; Holt JT
Methods Mol Med; 2000; 35():593-607. PubMed ID: 21390833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
